Myriad Genetics Delivers Strong Revenue and Earnings Growth in June 2021 Quarter, Continues to Execute on Strategic Growth & Transformation Plans

NEXT STORY
Global Disposable Gloves Market (2021 to 2026) – Featuring Top Globe, Kossan and Hartalega Among Others
PREV STORY
Rhythm Pharmaceuticals Reports Second Quarter 2021 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Iovance Biotherapeutics Announces Updated Phase 2 Clinical Data from the Lifileucel Metastatic Melanoma Trial at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting

38% Objective Response Rate (ORR) demonstrated in 47 Metastatic Melanoma patients who were unsuccessfully ...

author_avatar
NASDAQ Market News

Merus N.V. Announces Proposed Public Offering of Common Shares

author_avatar
NASDAQ Market News

Tiziana Life Sciences plc (“Tiziana” or the “Company”) – Tiziana Files Registration Statement on Form F-3 with U.S. Securities and Exchange Commission

author_avatar
NASDAQ Market News